Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07103044 · ClinicalTrials.gov registry record · NA

Early Achievements - Shaping Early Language and Literacy Skills

A NA study of Developmental Language Disorder, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
1
Study location

NCT07103044 is a NA study of Developmental Language Disorder that is actively recruiting participants, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 360 participants, above the 161-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (124% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07103044, a NA study of Developmental Language Disorder, is actively recruiting participants, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
1
Study location

Study Summary

Language skills are important for long-term reading comprehension success. Yet there are limited instructional approaches available for prekindergarten (pre-K) teachers to use in their inclusive classrooms to boost literacy-related language skills in children with and without language delays or disorders. In the first part of this study, the investigators will develop a teacher training program focused on building pre-K children's language-based literacy skills. Teachers will be trained and will use the strategies that they learn during literacy-related activities in their inclusive pre-K classrooms. Their students' language-related literacy skills will be measured before and after their training. Based on teacher feedback and child assessment information, the training program will be revised. In the final part of the study, a preliminary randomized control trial (RCT) will be done using the revised training approach. The results of the RCT will help the investigators know if the teacher training program helps to improve the effectiveness of teachers' instruction and their students' development of language-related literacy skills. The primary goal of this research study is to determine whether study-trained pre-K teachers in inclusive early childhood education classrooms use more effective teaching strategies than teachers who do not receive the training. A secondary goal of this research study is to determine if this teacher training program strengthens language-related literacy skills for students with and without language disorders or delays. The research team hypothesizes that teachers who participate in the training program will use effective teaching strategies more often than teachers who do not receive the training. Additionally, the investigators predict that teachers who receive the training will feel more confident teaching early language-based literacy skills to their students (with and without language delays/disorders) than teachers who do not receiv

Interventions

  • BEHAVIORAL Early Achievements - Shaping Early Language and Literacy Skills

Study Locations (1)

Maryland

  • Kennedy Krieger Institute - Baltimore

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2021-08-26
Est. Completion 2026-10-31
Phase NA

What the Registry Record Tells You About NCT07103044

The ClinicalTrials.gov registry entry for NCT07103044 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 161-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (124% higher). The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Developmental Language Disorder appearing as the primary indexed condition, and to 1 intervention - of which Early Achievements - Shaping Early Language and Literacy Skills is the first listed.

NCT07103044 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT07103044 about?

NCT07103044 is a clinical study titled "Early Achievements - Shaping Early Language and Literacy Skills". Language skills are important for long-term reading comprehension success. Yet there are limited instructional approaches available for prekindergarten (pre-K) teachers to use in their inclusive classrooms to boost literacy-related language skills in children with and without language delays or diso...

What is the current status of trial NCT07103044?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2021-08-26. Estimated completion is 2026-10-31.

What conditions does trial NCT07103044 study?

This clinical trial studies the following conditions: Developmental Language Disorder.

What interventions are being tested in trial NCT07103044?

The interventions under investigation include: Early Achievements - Shaping Early Language and Literacy Skills (BEHAVIORAL).

Who is sponsoring clinical trial NCT07103044?

This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07103044 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Language Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.